Bioactive and therapeutic ROMP polymers

Polymer Reviews

Volumn 47, Issue 3, 2007, Pages 419-459

  Smith, Deedee ^a   Pentzer, Emily B ^a   Nguyen, Sonbinh T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Drug delivery; Plymer nanoparticles; Polymer micelles; Polymer therapeutics; ROMP; Targeting

Indexed keywords

MULTIVALENT SCAFFOLDS; POLYMER MICELLES; POLYMER THERAPEUTICS; THERAPEUTIC AGENTS;

BIOACTIVITY; BLOCK COPOLYMERS; DRUG DELIVERY; MICELLES; NANOPARTICLES; SYNTHESIS (CHEMICAL);

BIOPOLYMERS;

EID: 34547773189     PISSN: 15583724     EISSN: 15583716     Source Type: Journal    
DOI: 10.1080/15583720701455186     Document Type: Article

References (204)

1. Trimmel, G.; Riegler, S.; Fuchs, G.; Slugovc, C.; Stelzer, F. " Liquid crystalline polymers by metathesis polymerization" , Adv. Polym. Sci. 2005, 176, 43-87.
2. Buchmeiser, M. R. " Metathesis polymerization to and from surfaces" , Adv. Polym. Sci. 2006, 197, 137-171.
3. Anderson, A. W.; Merckling, N. G US Patent 2721189, 1955.
4. Eleuterio, H. S US Patent 3074918, 1960.
5. Hérisson, J. L.; Chauvin, Y. " Catalysis of olefin transformations by tungsten complexes. II. Telomerization of cyclic olefins in the presence of acyclic olefins" , Makromol. Chem. 1970, 141, 161-176.
6. Grubbs, R. H.; Burk, P. L.; Carr, D. D. " Mechanism of the olefin metathesis reaction" , J. Am. Chem. Soc. 1975, 97, 3265-3267.
7. Grubbs, R. H.; Carr, D. D.; Hoppin, C.; Burk, P. L. " Consideration of the mechanism of the metal-catalyzed olefin metathesis reaction" , J. Am. Chem. Soc. 1976, 98, 3478-3483.
8. Katz, T. J.; McGinnis, J. " Mechanism of the olefin metathesis reaction" , J.Am. Chem. Soc. 1975, 97, 1592-1594.
9. Katz, T. J.; Rothchild, R. " Mechanism of the olefin metathesis of 2,2′-divinylbiphenyl" , J. Am. Chem. Soc. 1976, 98, 2519-2526.
10. Schrock, R.; Rocklage, S.; Wengrovius, J.; Rupprecht, G.; Fellmann, J. " Preparation and characterization of active niobium, tantalum and tungsten metathesis catalysts" , J. Mol. Catal. 1980, 8, 73-83.
11. Casey, C. P.; Burkhardt, T. J. " Reactions of (diphenylcarbene) pentacarbonyltungsten(0) with alkenes. Role of metal-carbene complexes in cyclopropanation and olefin metathesis reactions" , J. Am. Chem. Soc. 1974, 96, 7808-7809.
12. Adlhart, C.; Chen, P. " Mechanism and activity of ruthenium olefin metathesis catalysts: The role of ligands and substrates from a theoretical perspective" , J. Am. Chem. Soc. 2004, 126, 3496-3510.
13. Anslyn, E. V.; Grubbs, R. H. " Mechanism of titanocene metallacyclobutane cleavage and the nature of the reactive intermediate" , J. Am. Chem. Soc. 1987, 109, 4880-4890.
14. Mocella, M. T.; Busch, M. A.; Muetterties, E. L. " Olefin metathesis reaction. III. Mechanistic considerations" , J. Am. Chem. Soc. 1976, 98, 1283-1285.
15. Puddephatt, R. J.; Quyser, M. A.; Tipper, C. F. H. " Easy isomerization of a metallocyclobutane complex, and its relevance to the mechanism of olefin metathesis" , J. Chem. Soc., Chem. Commun. 1976, 626-627.
16. Schrock, R. R. " Alkylcarbene complex of tantalum by intramolecular α-hydrogen abstraction" , J. Am. Chem. Soc. 1974, 96, 6796-6797.
17. Schrock, R. R. " First isolable transition metal methylene complex and analogs. Characterization, mode of decomposition, and some simple reactions" , J. Am. Chem. Soc. 1975, 97, 6577-6578.
18. Howard, T. R.; Lee, J. B.; Grubbs, R. H. " Titanium metallacarbene-metallacyclobutane reactions: Stepwise metathesis" , J. Am. Chem. Soc. 1980, 102, 6876-6878.
19. Gilliom, L. R.; Grubbs, R. H. " Titanacyclobutanes derived from strained, cyclic olefins: The living polymerization of norbornene" , J. Am, Chem. Soc. 1986, 108, 733-742.
20. Riegler, S.; Slugovc, C.; Trimmel, G.; Stelzer, F. " Block copolymers via ROMP-awakening the sleeping beauty" , Macromol. Symp. 2004, 217, 231-246.
21. de la Escosura, A.; Martinez-Diaz, M. V.; Torres, T.; Grubbs, R. H.; Guldi, D. M.; Neugebauer, H.; Winder, C.; Drees, M.; Sariciftci, N. S. " New donor-acceptor materials based on random polynorbornenes bearing pendant phthalocyanine and fullerene units" , Chem.-Asian J. 2006, 1, 148-154.
22. Bissinger, P US Patent 904766, 1999.
23. Rutenberg, I. M.; Scherman, O. A.; Grubbs, R. H.; Jiang, W.; Garfunkel, E.; Bao, Z. " Synthesis of polymer dielectric layers for organic thin film transistors via surface-initiated ring-opening metathesis polymerization" , J. Am. Chem. Soc. 2004, 126, 4062-4063.
24. Schrock, R. R.; Feldman, J.; Cannizzo, L. F.; Grubbs, R. H. " Ring-opening polymerization of norbornene by a living tungsten alkylidene complex" , Macromolecules 1987, 20, 1169-1172.
25. Totland, K. M.; Boyd, T. J.; Lavoie, G. G.; Davis, W. M.; Schrock, R. R. " Ring-opening metathesis polymerization with binaphtholate or biphenolate complexes of molybdenum" , Macromolecules 1996, 29, 6114-6125.
26. 2Me)" , J. Am. Chem. Soc. 1993, 115, 4413-4414.
27. Oskam, J. H.; Schrock, R. R. " Rotational isomers of molybdenum(VI) alkylidene complexes and cis/trans polymer structure: Investigations in ring-opening metathesis polymerization" , J. Am. Chem. Soc. 1993, 115, 11831-11845.
28. O'Dell, R.; McConville, D. H.; Hofmeister, G. E.; Schrock, R. R. " Polymerization of enantiomerically pure 2,3-dicarboalkoxynorbornadienes and 5,6-disubstituted norbornenes by wellcharacterized molybdenum ring-opening metathesis polymerization initiators. Direct determination of tacticity in cis, highly tactic and trans, highly tactic polymers" , J. Am. Chem. Soc. 1994, 116, 3414-3423.
29. Coperet, C.; Lefebvre, F.; Basset, J.-M. From ill-defined W alkylidene complexs, In Handbook of Metathesis; Grubbs, R. H., Ed.; Wiley-VCH: Weinheim, 2003; Vol. 1, pp 33-46.
30. 2] and their reactions" , Angew. Chem., Int. Ed. Engl. 1995, 34, 2039-2041.
31. 2: The influence of the alkylidene moiety on metathesis activity" , J. Am. Chem Soc. 1996, 118, 100-110.
32. Trnka, T. M.; Morgan, J. P.; Sanford, M. S.; Wilhelm, T. E.; Scholl, M.; Choi, T.-L.; Ding, S.; Day, M. W.; Grubbs, R. H. " Synthesis and activity of ruthenium alkylidene complexes coordinated with phosphine and N-heterocyclic carbene ligands" , J. Am. Chem. Soc. 2003, 125, 2546-2558.
33. Adlhart, C.; Chen, P. " Comparing intrinsic reactivities of the first- and second-generation ruthenium metathesis catalysts in the gas phase" , Helv. Chim. Acta 2003, 86, 941-949.
34. Frenzel, U.; Nuyken, O.; Kohl, F. J.; Schattenmann, W. C.; Weskamp, T.; Herrmann, W. A. " Ring-opening metathesis polymerization using new ruthenium alkylidene complexes with N-heterocyelic carbene ligands" , Polym. Mater. Sci. Eng. 1999, 80, 135-136.
35. Straub, B. F. " Origin of the high activity of second-generation Grubbs catalysts" , Angew. Chem., Int. Ed. Engl. 2005, 44, 5974-8.
36. Slugovc, C. " The ring opening metathesis polymerisation toolbox" , Macromol. Rapid Commun. 2004, 25, 1283-1297.
37. Frenzel, U.; Nuyken, O. " Ruthenium-based metathesis initiators: Development and use in ring-opening metathesis polymerization" , J. Polym. Sci., Part A: Polym. Chem. 2002, 40, 2895-2916.
38. Love, J. A.; Morgan, J. P.; Trnka, T. M.; Grubbs, R. H. " A practical and highly active ruthenium-based catalyst that effects the cross metathesis of acrylonitrile" , Angew. Chem., Int. Ed. 2002, 41, 4035-4037.
39. Black, G.; Maher, D.; Risse, W. Living ring-opening olefin metathesis polymerizations, In Handbook of Metathesis; Grubbs, R. H., Ed.; Wiley-VCH: Weinheim, 2003; Vol. 3, pp 2-71.
40. Szwarc, M. " Living polymers. Their discovery, characterization, and properties" , J. Polym. Sci., Part A: Polym. Chem. 1998, 36, ix.
41. Matyjaszewski, K. " Introduction to living polymerization. Living and/or controlled polymerization" , J. Phys. Org. Chem. 1995, 8, 197-207.
42. Duncan, R. " Polymer conjugates as anticancer nanomedicines" , Nat. Rev. Cancer 2006, 6, 688-701.
43. Duncan, R.; Ringsdorf, H.; Satchi-Fainaro, R. " Polymer therapeutics-polymers as drugs, drug and protein conjugates and gene delivery systems: Past, present and future opportunities" , /. Drug Targeting 2006, 14, 337-341.
44. Ferrari, M. " Cancer nanotechnology: Opportunities and challenges" , Nat. Rev. Cancer 2005, 5, 161-171.
45. Haag, R.; Kratz, F. " Polymer therapeutics: Concepts and applications" , Angew. Chem., Int. Ed. 2006, 45, 1198-1215.
46. Kiessling, L. L.; Owen, R. M. Synthesis and applications of bioactive polymers generated by ring-opening metathesis polymerization, In Handbook of Metathesis; Grubbs, R. H., Ed.; Wiley-VCH: Weinheim, 2003; Vol. 3, pp 180-225.
47. Kiessling, L. L.; Strong, L. E. " Bioactive polymers" , Top. Organometallic Chem. 1998, 1, 199-231.
48. Dragutan, V.; Dimonie, M. Olefin Metathesis and Ring-Opening Polymerization of Cyclo-Olefins; Wiley: New York, 1985; p 554.
49. Grubbs, R. H.; Novak, B. M. US Patent 4883851, 1989.
50. Murdzek, J. S.; Schrock, R. R. " Low polydispersity homopolymers and block copolymers by ring opening of 5,6-dicarbomethoxynorbornene" , Macromolecules 1987, 20, 2640-2642.
51. Young, J. W.; Sharpless, K. B. " The ring-opening metathesis polymerization of 7-oxabicyclo[2.2.1]hept-5-ene derivatives: A new acyclic polymeric ionophore" , Chemtracts: Org. Chem. 1988, 1, 240-242.
52. Singla Anil, K.; Garg, A.; Aggarwal, D. " Paclitaxel and its formulations" , Int. J. Pharm. 2002, 235, 179-192.
53. Fawaz, F.; Bonini, F.; Guyot, M.; Lagueny, A. M.; Fessi, H.; Devissaguet, J. P. " Disposition and protective effect against irritation after intravenous and rectal administration of indomethacin loaded nanocapsules to rabbits" , Int. J. Pharm. 1996, 133, 107-115.
54. Matsumura, Y.; Maeda, H. " A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS" , Cancer Res. 1986, 46, 6387-6392.
55. Maeda, H.; Seymour, L. W.; Miyamoto, Y. " Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo" , Bioconjugate Chem. 1992, 3, 351-362.
56. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. " Tumor vascular permeability and the EPR effect in macromolecular therapeutics. A review" , J. Controlled Release 2000, 65, 271-284.
57. Duncan, R. " The dawning era of polymer therapeutics" , Nat. Rev. Drug Discovery 2003, 2, 347-360.
58. Chytil, P.; Etrych, T.; Konak, C.; Sirova, M.; Mrkvan, T.; Rihova, B.; Ulbrich, K. " Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification" , J. Controlled Release 2006, 115, 26-36.
59. Greco, F.; Vicent, M. J.; Penning, N. A.; Nicholson, R. I.; Duncan, R. " HPMA copolymer-aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines" , J. Drug Targeting 2005, 13, 459-470.
60. Kovar, M.; Kovar, L.; Subr, V.; Etrych, T.; Ulbrich, K.; Mrkvan, T.; Loucka, J.; Rihova, B. " HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: Comparison of biological properties in vitro" , J. Controlled Release 2004, 99, 301-314.
61. Rihova, B. " Antibody-targeted HPMA copolymer-bound anthracycline antibiotics" , Drugs Future 2003, 28, 1189-1210.
62. David, A.; Kopeckova, P.; Minko, T.; Rubinstein, A.; Kopecek, J. " Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells" , Eur. J. Cancer 2004, 40, 148-157.
63. Jelinkova, M.; Strohalm, J.; Etrych, T.; Ulbrich, K.; Rihova, B. " Starlike vs. classic macromolecular prodrugs: Two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs" , Pharm. Res. 2003, 20, 1558-1564.
64. Watson, K. J.; Anderson, D. R.; Nguyen, S. T. " Toward polymeric anticancer drug cocktails from ring-opening metathesis polymerization" , Macromolecules 2001, 34, 3507-3509.
65. Olsen, N. V.; Jensen, N. G.; Hansen, J. M.; Christensen, N. J.; Fogh-Andersen, N.; Kanstrup, I.-L. " Non-steroidal anti-inflammatory drugs and renal response to exercise: A comparison of indomethacin and nabumetone" , Clin. Sci. 1999, 97, 457-465.
66. Golab, J.; Kozar, K.; Kaminski, R.; Czajka, A.; Marczak, M.; Switaj, T.; Giermasz, A.; Stoklosa, T.; Lasek, W.; Zagozdzon, R.; Mucha, K.; Jakobisiak, M. " Interleukin 1.2 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice" , Life Sci. 2000, 66, 1223-1230.
67. Kashiyama, E.; Hutchinson, I.; Chua, M.-S.; Stinson, S. F.; Phillips, L. R.; Kaur, G.; Sausville, E. A.; Bradshaw, T. D.; Westwell, A. D.; Stevens, M. F. G. " Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles" , J. Med. Chem. 1999, 42, 4172-4184.
68. Beyer, U.; Roth, T.; Schumacher, P.; Maier, G.; Unold, A.; Frahm, A. W.; Fiebig, H. H.; Unger, C.; Kratz, F. " Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil" , J. Med. Chem. 1998, 41, 2701-2708.
69. McElwain, T. J.; Toy, J.; Smith, E.; Peckham, M. J.; Austin, D. E. " A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease" , Br. J. Cancer 1977, 36, 276-280.
70. Helmlinger, G.; Sckell, A.; Dellian, M.; Forbes, N. S.; Jain, R. K. " Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism" , Clin. Cancer Res. 2002, 8, 1284-1291.
71. Marshall, T. H.; Akgun, A. " Specificity of porcine elastase and a-chymotrypsin. Effect of fatty acid chain length in a homologous series of nitrophenyl esters" , J. Biol. Chem. 1971, 246, 6019-6023.
72. Seymour, L. W.; Ferry, D. R.; Anderson, D.; Hesslewood, S.; Julyan, P. J.; Poyner, R.; Doran, J.; Young, A. M.; Buttles, S.; Kerr, D. J. " Hepatic drug targeting: Phase I evaluation of polymer-bound doxorubicin" , J. Clin. Oncol. 2002, 20, 1668-1676.
73. Nori, A.; Kopecek, J. " Intracellular targeting of polymer-bound drugs for cancer chemotherapy" , Adv. Drug Delivery Rev. 2005, 57, 609-636.
74. Allen, T. M.; Hansen, C.; Martin, F.; Redemann, C.; Yau-Young, A. " Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo" , Biochim. Biophys. Acta 1991, 1066, 29-36.
75. Maeda, H.; Kabanov, A.; Kataoka, K.; Okano, T. Eds. Polymer Drugs in the Clinical Stage: Advantages and Prospects; Kluwer Academic/Plenum Publishers: New York, 2003, p 224.
76. Carrillo, A.; Kane, R. S. " Block copolymer nanoparticles of controlled sizes via ring-opening metathesis polymerization" , J. Polym. Sci., Part A: Polym. Chem. 2004, 42, 3352-3359.
77. Stubenrauch, K.; Moitzi, C.; Fritz, G.; Glatter, O.; Trimmel, G.; Stelzer, F. " Precise tuning of micelle, core, and shell size by the composition of amphiphilic block, copolymers derived from ROMP investigated by DLS and SAXS" , Macromolecules 2006, 39, 5865-5874.
78. Choucair, A.; Eisenberg, A. " Interfacial solubilization of model amphiphilic molecules in block copolymer micelles" , J. Am. Chem. Soc. 2003, 125, 11993-2000.
79. Nguyen, D.; Williams, C. E.; Eisenberg, A. " Block ionomer micelles in solution. 1. Characterization of ionic cores by small-angle X-ray scattering" , Macromolecules 1994, 27, 5090-5093.
80. Djordjevic, J.; Barch, M.; Uhrich, K. E. " Polymeric micelles based on amphiphilic scorpionlike macromolecules: Novel carriers for water-insoluble drugs" , Pharm. Res. 2005, 22, 24-32.
81. Wike-Hooley, J. L.; Haveman, J.; Reinhold, H. S. " The relevance of tumour pH to the treatment of malignant disease" , Radiother. Oncol. 1984, 2, 343-366.
82. Bertin, P. A.; Watson, K. J.; Nguyen, S. T. " Indomethacin- containing nanoparticles derived from amphiphilic polynorbornene: A model ROMP-based drug encapsulation system" , Macromolecules 2004, 37, 8364-8372.
83. Quemener, D.; Heroguez, V.; Gnanou, Y. " Synthesis of acid-sensitive latices by ring-opening metathesis polymerization" , J. Polym. Sci., Part A: Polym. Chem. 2005, 43, 217-229.
84. Bertin, P. A.; Smith, D.; Nguyen, S. T. " High-density doxorubicin-conjugated polymeric nanoparticles via ring-opening metathesis polymerization" , Chem. Commun. 2005, 3793-3795.
85. Hortobagyi, G. N. " Anthracyclines in the treatment of cancer. An overview" , Drugs 1997, 54, 1-7.
86. Smith, D.; Chen, C. K.-F.; Nguyen, S. T. Unpublished observation.
87. Lechardeur, D.; Lukacs Gergely, L. " Intracellular barriers to non-viral gene transfer" , Curr. Gene Ther. 2002, 2, 183-194.
88. Cheng, X.; Ming, X.; Croyle, M. A. " PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route" , Pharm. Res. 2003, 20, 1444-1451.
89. Djeha, H. A.; Todryk, S. M.; Pelech, S.; Wrighton, C. J.; Irvine, A. S.; Mountain, A.; Lipinski, K. S. " Antitumor immune responses mediated by adenoviral GDEPT using nitroreductase/CB1954 is enhanced by high-level coexpression of heat shock protein 70" , Cancer Gene Ther. 2005, 12, 560-571.
90. Skog, J.; Edlund, K.; Widegren, B.; Salford, L. G.; Wadell, G.; Mei, Y.-F. " Efficient internalization into low-passage glioma cell lines using adenoviruses other than type 5: An approach for improvement of gene delivery to brain tumors" , J. Gen. Virol, 2004, 85, 2627-2638.
91. Varga, C. M.; Tedford, N. C.; Thomas, M.; Klibanov, A. M.; Griffith, L. G.; Lauffenburger, D. A. " Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes" , Gene Ther. 2005, 12, 1023-1032.
92. Ohsaki, M.; Okuda, T.; Wada, A.; Hirayama, T.; Niidome, T.; Aoyagi, H. " In vitro gene transfection using dendritic poly(L)-lysine" , Bioconjugate Chem. 2002, 13, 510-517.
93. Tmbetskoy, V. S.; Torchilin, V. P.; Kennel, S. J.; Huang, L. " Use of N-terminal modified poly(L)-lysine-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells" , Bioconjugate Chem. 1992, 3, 323-327.
94. Choi, Y. H.; Liu, F.; Park, J. S.; Kim, S. W. " Lactose- poly(ethylene glycol)-grafted poly-(L)-lysine as hepatoma cell-targeted gene carrier" , Bioconjugate Chem. 1998, 9, 708-718.
95. Shima, S.; Sakai, H. " Polylysine produced by Streptomyces" , Agric. Biol. Chem. 1977, 41, 1807-1809.
96. Deming, T. J. " Living polymerization of α-amino acid-N-carboxyanhydrides" , J. Polym. Sci., Part A: Polym. Chem. 2000, 38, 3011-3018.
97. Lv, H.; Zhang, S.; Wang, B.; Cui, S.; Yan, J. " Toxicity of cationic lipids and cationic polymers in gene delivery" , J. Controlled Release 2006, 114, 100-109.
98. Asgatay, S.; Franceschi-Messant, S.; Perez, E.; Vicendo, P.; Rico-Lattes, I.; Phez, E.; RoIs, M. P. " Polynorbornene polycationic polymers as gene transfer agents" , Int. J. Pharm. 2004, 285, 121-133.
99. Harned, A. M.; Probst, D. A.; Sheriff, B. A.; Poon, K. W. C.; Hanson, P. R.; Wiethoff, C.; Middaugh, C. R. " Ring-opening metathesis polymerization strategies to chemical and biological delivery agents" , Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) 2001, 42, 143-144.
100. Liaw, D.-J.; Chen, T.-P.; Huang, C.-C. " Self-assembly aggregation of highly stable copolynorbornenes with amphiphilic architecture via ring-opening metathesis polymerization" , Macromolecules 2005, 38, 3533-3538.
101. Liaw, D.-J.; Chen, T.-P.; Huang, C.-C. " Novel active ester-bridged copolynorbornene materials containing terminal functional hydroxyl, amino, methacryloyl, or ammonium groups via ring-opening metathesis polymerization" , J. Polym. Sci., Part A: Polym, Chem. 2005, 43, 4233-4247.
102. Liaw, D.-J.; Huang, C.-C; Kang, E.-T. " Effects of the architecture and environment on polymeric molecular assemblies of novel amphiphilic diblock copolynorbornenes with narrow polydispersity via living ring-opening metathesis polymerization" , J. Polym. Sci., Part A: Polym. Chem. 2006, 44, 2901-2911.
103. Allen, T. M. " Ligand-targeted therapeutics in anticancer therapy" , Nat. Rev. Cancer 2002, 2, 750-763.
104. Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P. Eds. Molecular Biology of the Cell, 4th edn.; Garland Science, Taylor and Francis Group: New York, 2002, p 1463.
105. Panchal, R. G. " Novel therapeutic strategies to selectively kill cancer cells" , Biochem. Pharmacol. 1998, 55, 247-252.
106. Dyba, M.; Tarasova, N. I.; Michejda, C. J. " Small molecule toxins targeting tumor receptors" , Curr. Pharm. Des. 2004, 10, 2311-2334.
107. Schrama, D.; Reisfeld, R. A.; Becker, J. C. " Antibody targeted drugs as cancer therapeutics" , Nat. Rev. Drug Discovery 2006, 5, 147-159.
108. Torchilin, V. P. " Drug targeting" , Eur. J. Pharm. Sci. 2000, 11, S81-S91.
109. Lundberg, P.; Langel, U. " A brief introduction to cell-penetrating peptides" , J. Mol. Recognit. 2003, 16, 227-233.
110. Lu, Y.; Low, P. S. " Folate-mediated delivery of macromolecular anticancer therapeutic agents" , Adv. Drug Delivery Rev. 2002, 54, 675-693.
111. Gabius, H.-J.; Siebert, H.-C.; Andre, S.; Jimenez-Barbero, J.; Ruediger, H. " Chemical biology of the sugar code" , ChemBioChem 2004, 5, 740-764.
112. Jaracz, S.; Chen, J.; Kuznetsova, L. V.; Ojima, I. " Recent advances in tumor-targeting anticancer drug conjugates" , Bioorg. Med. Chem. 2005, 13, 5043-5054.
113. Dass, C. R.; Choong, P. F. M. " Targeting of small molecule anticancer drugs to the tumor and its vasculature using cationic liposomes: Lessons from gene therapy" , Cancer Cell Intern. 2006, 6, 17.
114. Joralemon, M. J.; O'Reilly, R. K.; Hawker, C. J.; Wooley, K. L. " Shell click-crosslinked (SCC) nanoparticles: A new methodology for synthesis and orthogonal functionalization" , J. Am. Chem. Soc. 2005, 127, 16892-16899.
115. Bertin, P. A.; Gibbs, J. M.; Shen, C. K.-F.; Thaxton, C. S.; Russin, W. A.; Mirkin, C. A.; Nguyen, S. T. " Multifunctional polymeric nanoparticles from diverse bioactive agents" , J. Am. Chem. Soc. 2006, 128, 4168-4169.
116. Milella, M.; Trisciuoglio, D.; Bruno, T.; Ciuffreda, L.; Mottolese, M.; Cianciulli, A.; Cognetti, F.; Zangemeister-Wittke, U.; Del Bufalo, D.; Zupi, G. " Trastuzumab downregulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene-amplified breast cancer cells" , Clin. Cancer Res. 2004, 10, 7747-7756.
117. Dettmer, C.; Nguyen, S. T. Unpublished result.
118. Owen, R. M.; Gestwicki, J. E.; Young, T.; Kiessling, L. L. " Synthesis and applications of end-labeled neoglycopolymers" , Org. Lett. 2002, 4, 2293-2296.
119. Allen, M. J.; Raines, R. T.; Kiessling, L. L. " Contrast agents for magnetic resonance imaging synthesized with ring-opening metathesis polymerization" , J. Am. Chem. Soc. 2006, 128, 6534-6535.
120. Katayama, H.; Fukuse, Y.; Nobuto, Y.; Akamatsu, K.; Ozawa, F. " Ring-opening metathesis polymerization using alkenyl sulfides as chain-transfer agents: Efficient routes to unsymmetrical poly(norbornene)-based macroinitiators bearing a terminal hydroxy group" , Macromolecules 2003, 36, 7020-7026.
121. Yang, Z.-Q.; Puffer, E. B.; Pontrello, J. K.; Kiessling, L. L. " Synthesis of a multivalent display of a CD22-binding trisaccharide" , Carbohydr. Res. 2002, 337, 1605-1613.
122. Chen, B.; Metera, K.; Sleiman, H. F. " Biotin-terminated ruthenium bipyridine ring-opening metathesis polymerization copolymers: Synthesis and self-assembly with streptavidin" , Macromolecules 2005, 38, 1084-1090.
123. Wilchek, M.; Bayer Edward, A.; Livnah, O. " Essentials of biorecognition: The (strept)avidinbiotin system as a model for protein-protein and protein-ligand interaction" , Immunol. Lett. 2006, 103, 27-32.
124. Torchilin, V. P. " Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate" , Adv. Drug Delivery Rev. 2004, 57, 95-109.
125. Chen, B.; Sleiman, H. F. " Ruthenium bipyridine-containing polymers and block copolymers via ring-opening metathesis polymerization" , Macromolecules 2004, 37, 5866-5872.
126. Okada, Y. " Synthesis of peptides by solution methods" , Curr. Org. Chem. 2001, 5, 1.-43.
127. Roberts, K. S.; Sampson, N. S. " A facile synthetic method to prepare fluorescently labeled ROMP polymers" , Org. Lett. 2004, 6, 3253-3255.
128. Gregoriadis, G.; Ryman, B. E. " Liposomes as carriers of enzymes or drugs: A new approach to the treatment of storage diseases" , Biochem. J. 1971, 124, 58.
129. Gillies, E. R.; Frechet, J. M. J. " pH-responsive copolymer assemblies for controlled release of doxorubicin" , Bioconjugate Chem. 2005, 16, 361-368.
130. Bontha, S.; Kabanov, A. V.; Bronich, T. K. " Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs" , J. Controlled Release 2006, 114, 163-174.
131. Kallinteri, P.; Higgins, S.; Hutcheon, G. A.; St Pourcain, C. B.; Garnett, M. C. " Novel functionalized biodegradable polymers for nanoparticle drug delivery systems" , Biomacromolecules 2005, 6, 1885-1894.
132. Choi, T.-L.; Grubbs, R. H. " Mild one-step core-shell micelles formation by living ring-opening metathesis polymerization" , Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) 2003, 44, 669-670.
133. Kiessling, L. L.; Gestwicki, J. E.; Strong, L. E. " Synthetic multivalent ligands in the exploration of cell-surface interactions" , Curr. Opin. Chem. Biol. 2000, 4, 696-703.
134. Kiessling, L. L.; Gestwicki, J. E.; Strong, L. E. " Synthetic multivalent ligands as probes of signal transduction" , Angew. Chem., Int. Ed. 2006, 45, 2348-2368.
135. Gestwicki, J. E.; Cairo, C. W.; Strong, L. E.; Oetjen, K. A.; Kiessling, L. L. " Influencing receptor-ligand binding mechanisms with multivalent ligand architecture" , J. Am, Chem. Soc. 2002, 124, 14922-14933.
136. Mammen, M.; Chio, S.-K.; Whitesides, G. M. " Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors" , Angew. Chem. Int. Ed. 1998, 37, 2755-2794.
137. Biagini, S. C. G.; Coles, M. P.; Gibson, V. C.; Giles, M. R.; Marshall, E. L.; North, M. " Living ring-opening metathesis polymerization of amino ester functionalized norbornenes" , Polymer 1998, 39, 1007-1014.
138. Biagini, S. C. G.; Davies, R. G.; Gibson, V. C.; Giles, M. R.; Marshall, E. L.; North, M.; Robson, D. A. " The synthesis and ring-opening metathesis polymerization of peptide-functionalized norbornenes" , Chem. Commun. 1999, 235-236.
139. Coles, M. P.; Gibson, V. C.; Mazzariol, L.; North, M.; Teasdale, W. G.; Williams, C. M.; Zamuner, D. " Amino acid-derived homochiral polymers via ring-opening metathesis polymerization" , J. Chem. Soc., Chem. Commun. 1994, 2505-2506.
140. Sutthasupa, S.; Terada, K.; Sanda, F.; Masuda, T. " Ring-opening metathesis polymerization of amino acid-functionalized norbornene derivatives" , J. Polym. Sci., Part A: Polym. Chem. 2006, 44, 5337-5343.
141. Rule, J. D.; Moore, J. S. " ROMP reactivity of endo- and exo-dicyclopentadiene" , Macromolecules 2002, 35, 7878-7882.
142. Lapinte, V.; Brosse, J.-C.; Fontaine, L. " Synthesis and ring-opening metathesis polymerization (ROMP) reactivity of endo- and exo-norbornenylazlactone using ruthenium catalysts" , Macromol. Chem. Phys. 2004, 205, 824-833.
143. Saiki, I. " Cell adhesion molecules and cancer metastasis" , Jpn. J. Pharmacol. 1997, 75, 215-242.
144. Maynard, H. D.; Okada, S. Y.; Grubbs, R. H. "Synthesis of norbornenyl polymers with bioactive oligopeptides by ring-opening metathesis polymerization", Macromolecules 2000, 33, 6239-6248.
145. Ruoslahti, E.; Pierschbacher, M. D. "New perspectives in cell adhesion: RGD and integrins", Science (Washington, DC) 1987, 238, 491-497.
146. Aota, S.; Nomizu, M.; Yamada, K. M. "The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function", J. Biol., Chem. 1994, 269, 24756-24761.
147. Pierschbacher, M. D.; Polarek, J. W.; Craig, W. S.; Tschopp, J. F.; Sipes, N. J.; Harper, J. R. "Manipulation of cellular interactions with biomaterials toward a therapeutic outcome: A perspective", J. Cell., Biochem. 1.994, 56, 150-154.
148. Maynard, H. D.; Okada, S. Y.; Grubbs, R. H. "Inhibition of cell adhesion to fibronectin by oligopeptide-substituted polynorbomenes", J. Am. Chem. Soc. 2001, 123, 1275-1279.
149. Roberts, K. S.; Sampson, N. S. "Increased polymer length of oligopeptide-substituted polynorbomenes with LiCl", J. Org. Chem. 2003, 68, 2020-2023.
150. Roberts, K. S.; Konkar, S.; Sampson, N. S. "Comparison of fertilinb-peptide-substituted polymers and liposomes as inhibitors of in vitro fertilization", ChemBioChem 2003, 4, 1229-1231.
151. Carrillo, A.; Yanjarappa, M. J.; Gujraty, K. V.; Kane, R. S. "Biofunctionalized block copolymer nanoparticles based on ring-opening metathesis polymerization", J. Polym., Sci., Part A: Polym. Chem. 2005, 44, 928-939.
152. 1.52. Carrillo, A.; Gujraty, K. V.; Rai, P. R.; Kane, R. S. "Design of water-soluble, thiol-reactive polymers of controlled molecular weight: A novel multivalent scaffold", Nanotechnology 2005, 16, 416-421.
153. Hancock, R. E. W. "Mechanisms of action of newer antibiotics for gram-positive pathogens", Lancet Infect. Dis. 2005, 5, 209-218.
154. Kiessling, L. L.; Pohl, N. L. "Strength in numbers: Non-natural polyvalent carbohydrate derivatives", Chem. Biol. 1996, 3, 71-77.
155. Arimoto, H.; Nishimura, K.; Hayakawa, I.; Kinumi, T.; Uemura, D. "Multi-valent polymer of vancomycin: Enhanced antibacterial activity against VRE", Chem. Commun. 1999, 1361-1362.
156. Dinger, M. B.; Mol, J. C "Degradation of the first-generation Grubbs metathesis catalyst with primary alcohols, water, and oxygen. Formation and catalytic activity of ruthenium(II) monocarbonyl species", Organometallics 2003, 22, 1089-1095.
157. Zaehner, H.; Fiedler, H.-P. "The need for new antibiotics: Possible ways forward", Symp. Soci. Gen. Microbiol. 1995, 53, 67-84.
158. 1.58. Welling, M. M.; Paulusma-Annema, A.; Baiter, H. S.; Pauwels, E. K. J.; Nibbering, P. H. "Technetium-99 m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations", Eur. J. Nucl. Med. 2000, 27, 292-301.
159. Darveau, R. P.; Cunningham, M. D.; Seachord, C. L.; Cassiano-Clough, L.; Cosand, W. L.; Blake, J.; Watkins, C S. "ß-Lactam antibiotics potentiate Magainin II antimicrobial activity in vitro and in vivo", Antimicrob. Agents Chemother. 1991, 35, 1153-1159.
160. Giacometti, A.; Cirioni, O.; Barchiesi, F.; Scalise, G. "In vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus Aureus and interactions with clinically used antibiotics", Diagn. Microbiol., Infect. Dis. 2000, 38, 115-118.
161. Haynie, S. L.; Crum, G. A.; Doele, B. A. "Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin", Antimicrob. Agents Chemother. 1995, 39, 301-307.
162. Matsuzaki, K. "Why and how are peptide-lipid interactions utilized for self-defense? Magainins and Tachyplesins as archetypes", Biochim. Biophys. Acta, Biomembranes 1999, 1462, 1-10.
163. Yang, L.; Weiss, T. M.; Lehrer, R. I.; Huang, H. W. "Crystallization of antimicrobial pores in membranes: Magainin and Protegrin", Biophys. J. 2000, 79, 2002-2009.
164. Shai, Y. "Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by a-helical antimicrobial and cell non-selective membrane-lytic peptides", Biochim. Biophys. Acta, Biomembranes 1999, 1462, 55-70.
165. Yang, S. C.; Benita, S. "Enhanced absorption and drug targeting by positively charged submicron emulsions", Drug Dev. Res. 2000, 50, 476-486.
166. 1.66. Westerhoff, H. V.; Juretic, D.; Hendler, R. W.; Zasloff, M. "Magainins and the disruption of membrane-linked free-energy transduction", Proc Natl. Acad. Sci. U.S.A. 1989, 86, 6597-6601.
167. Bradshaw, J. P. "Cationic antimicrobial peptides: Issues for potential clinical use", BioDrugs 2003, 17, 233-240.
168. Zasloff, M. "Antimicrobial peptides of multicellular organisms", Nature (London) 2002, 415, 389-395.
169. Hancock, R. E. W.; Falla, T.; Brown, M. "Cationic bactericidal peptides", Adv. Microb. Physiol. 1995, 37, 135-175.
170. Bechinger, B.; Zasloff, M.; Opella, S. J. "Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy", Protein Sci. 1993, 2, 2077-2084.
171. Hamuro, Y.; Schneider, J. P.; DeGrado, W. F. "De Novo design of antibacterial ß-peptides", J. Am. Chem. Soc. 1999, 121, 12200-12201.
172. Porter, E. A.; Wang, X.; Lee, H. S.; Weisblum, B.; Gellman, S. H. "Non-haemolytic β-aminoacid oligomers", Nature (London) 2000, 404, 565.
173. Liu, D.; DeGrado, W. F. "De Novo design, synthesis, and characterization of antimicrobial ßpeptides"J. Am. Chem. Soc. 2001, 123, 7553-7559.
174. Fernandez-Lopez, S.; Kim, H. S.; Choi, E. C.; Delgado, M.; Granja, J. R.; Khasanov, A.; Kraehenbuehl, K.; Long, G.; Weinberger, D. A.; Wilcoxen, K. M.; Ghadiri, M. R. "Antibacterial agents based on the cyclic (D,L)-alpha-peptide architecture", Nature (London) 2001, 412, 452-455.
175. Kanazawa, A.; Ikeda, T.; Endo, T. "Polymeric phosphonium salts as a novel class of cationic biocides. II. Effects of counter anion and molecular weight on antibacterial activity of polymeric phosphonium salts", J. Polym. Sci., Part A: Polym. Chem. 1993, 31, 1441-1447.
176. Oh, J. E.; Hong, S. Y.; Lee, K. H. 'The comparison of characteristics between membraneactive antifungal peptide and its pseudopeptides", Bioorg. Med. Chem. 1999, 7, 2509-2515.
177. Ilker, M. F.; Schule, H.; Coughlin, E. B. "Modular norbornene derivatives for the preparation of well-defined amphiphilic polymers: Study of the lipid membrane disruption activities", Macromolecules 2004, 37, 694-700.
178. Ilker, M. F.; Nuesslein, K.; Tew, G. N.; Coughlin, E. B. "Tuning the hemolytic and antibacterial activities of amphiphilic polynorbornene derivatives", J. Am. Chem. Soc. 2004, 126, 15870-15875.
179. Breslow, D. S. "A polymer that fights cancer", Chemtech 1985, 15, 302-307.
180. Breslow, D. S.; Edwards, E. I.; Newburg, N. R. "Divinyl ether-maleic anhydride (pyran) copolymer used to demonstrate the effect of molecular weight on biological activity", Nature (London) 1973, 246, 160-162.
181. Munson, A. E.; Regelson, W.; Lawrence, W., Jr.; Wooles, W. R. "Biphasic response of the reticuloendothelial system (RES) induced by pyran copolymer", RES: J. Reticuloendothelial Soc. (1964-1973) 1970, 7, 375-385.
182. Tsou, H.-R. US Patent 616813, 1994.
183. Kaneda, Y.; Yamamoto, Y.; Tsunoda, S.-I.; Kamada, H.; Tsutsumi, Y.; Hirano, T.; Mayumi, T. "Bioconjugation of tumor necrosis factor-a with the copolymer of divinyl ether and maleic anhydride increasing its antitumor potency", Biochem. Biophys. Res. Commun. 1997, 239, 160-165.
184. Panaitescu, L.; Ottenbrite, R. M. "Biological effects and antitumor activity induced by benzocaine conjugated anionic polymers", J. Bioactive Compatible Polym. 2002, 17, 357-374.
185. Shimi, I. R.; Zaki, Z.; Shoukry, S.; Medhat, A. M. "A new antitumor substance, 7-oxabicyclo-(2.2.1)-5-heptene-2,3-dicarboxylic anhydride", Eur. J. Cancer Clin. Oncol. 1982, 18, 785-793.
186. Goldin, A. "Animal tumor model. Rationale of screening tests", Des. Clin. Trials Cancer Ther, Proc Course Clin. Pharmacol. 1973, 7-25.
187. Lu, S. Y.; Quayle, P.; Heatley, F.; Booth, C.; Yeates, S. G.; Padget, J. C. "Aqueous ringopening metathesis polymerization and copolymerization of 2,3-dicarboxylic acid anhydride, 2,3-bis(methoxymethyl), and 2,3-dicarboxylic acid monomethyl ester derivatives of 7-oxanorbornene", Eur. Polym. J. 1993, 29, 269-279.
188. Viswanathan, T.; Jethmalani, J.; Toland, A. "Homo- and copolymers of furan-maleic anhydride and furan-dimethylacetylene dicarboxylate adducts via aqueous ring-opening metathesis polymerization", J. Appl. Polym. Sci. 1993, 47, 1477-1480.
189. Buchmeiser, M. R.; Atzl, N.; Bonn, G. K. "Ring-opening-metathesis polymerization for the preparation of carboxylic-acid-functionalized, high-capacity polymers for use in separation techniques", J. Am. Chem. Soc. 1997, 119, 9166-9174.
190. Vygodskii, Y. S.; Shaplov, A. S.; Lozinskaya, E. I.; Filippov, O. A.; Shuvina, E. S.; Bandari, R.; Buchmeiser, M. R. "Ring-opening metathsis polymerization (ROMP) in ionic liquids: Scope and limitations", Macromolecules 2006, 39, 7821-7830.
191. Zhang, L.; Eisenberg, A. "Formation of crew-cut aggregates of various morphologies from amphiphilic block copolymers in solution", Polym. Adv. Technol. 1998, 9, 677-699.
192. Brannon-Peppas, L.; Blanchette, J. O. "Nanoparticle and targeted systems for cancer therapy", Adv. Drug Delivery Rev. 2004, 56, 1649-1659.
193. Muro, S.; Dziubla, T.; Qiu, W.; Leferovich, J.; Cui, X.; Berk, E.; Muzykantov, V. R. "Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1",./. Pharmacol. Exp. Ther. 2006, 317, 1161-1169.
194. Ding, B.-S.; Dziubla, T.; Shuvaev, V. V.; Muro, S.; Muzykantov, V. R. "Advanced drug delivery systems that target the vascular endothelium", Mol. Interv. 2006, 6, 98-112.
195. Wagner, E.; Kloeckner, J.; Ogris, M. "Optimizing polyplexes into synthetic viruses for tumortargeted gene therapy", Non-Viral Gene Ther. 2005, 237-245.
196. Vicent, M. J.; Duncan, R. "Polymer conjugates: Nanosized medicines for treating cancer", Trends Biotechnol. 2006, 24, 39-47.
197. Vasir, J. K.; Reddy, M. K.; Labhasetwar, V. D. "Nanosystems in drug targeting: Opportunities and challenges", Curr. Nanoscl 2005, 1, 47-64.
198. Ulbrich, K.; Etrych, T.; Chytil, P.; Jelinkova, M.; Rihova, B. "Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation", J. Drug Targeting 2004, 12, 477-489.
199. Farokhzad, O. C.; Jon, S.; Khademhosseini, A.; Tran, T.-N. T.; LaVan, D. A.; Langer, R. "Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells", Cancer Res. 2004, 64, 7668-7672.
200. Gao, W.; Hagnver, R.; Shah, V.; Xie, W.; Gross, R. A.; Iker, M. F.; Bell, C.; Burke, K. A.; Coughlin, E. B. "Glycolipid polymer synthesized from natural lactonic sophorolipids by ring-opening metathesis polymerization", Macromolecules 2007, 40, 145-147.
201. Hong, S. H.; Grubbs, R. H. "Highly active water-soluble olefin metathesis catalyst", J. Am. Chem. Soc. 2006, 128, 3508-3509.
202. Yao, Q.; Rodriguez Motta, A. "Immobilization of the Grubbs second-generation rutheniumcarbene complex on poly(ethylene glycol): A highly reactive and recyclable catalyst for ring-closing and cross-metathesis", Tetrahedron Lett. 2004, 45, 2447-2451.
203. Zarka, M. T.; Nuyken, O.; Weberskirch, R. "Polymer-bound, amphiphilic Hoveyda-Grubbstype catalyst for ring-closing metathesis in water", Macromol. Rapid Commun. 2004, 25, 858-862.
204. Breitenkamp, K.; Emrick, T. "Amphiphilic ruthenium benzylidene metathesis catalyst with PEG-substituted pyridine ligands", J. Poly. Sci., Part A: Polm. Chem. 2005, 43, 5429-5439.